Association between canakinumab dose and long-term remission in Still’s disease: insights from the AIDA network registry
Antonio Vitale, Valeria Caggiano, Jessica Sbalchiero, Giuseppe Lopalco et autres
0 citationsFrontiers in Pharmacology
Á. Robles Marhuenda
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
61Publications signalées
294Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Systemic Lupus Erythematosus ResearchInflammatory Myopathies and DermatomyositisImmunodeficiency and Autoimmune DisordersSarcoidosis and Beryllium Toxicity ResearchBlood disorders and treatments
Publications récentes
Long-term remission and monocyclic course in Still’s disease patients starting canakinumab early: data from the international AIDA network registry
Antonio Vitale, Valeria Caggiano, Jessica Sbalchiero, Giuseppe Lopalco et autres
1 citationSeminars in Arthritis and Rheumatism
1841 - SARCOIDOSIS Y CÁNCER: INCIDENCIA Y CRONOLOGÍA EN UNA COHORTE HOSPITALARIA
Elena Gloria Torres García, Elena Martínez Robles, Jorge Álvarez Troncoso, Á. Robles Marhuenda et autres
0 citationsRevista Clínica Española
POS1202 ANIFROLUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS: REAL-WORLD EFFICACY DATA FROM THE RELES REGISTRY INCEPTION COHORT
Iván Cusácovich, José Salvador García Morillo, M.A. Bahamonde-García, Francisco José García Hernández et autres
0 citationsAnnals of the Rheumatic Diseases
POS0313 PREVALENCE AND ORGAN-SPECIFIC PATTERNS OF CHRONIC IRREVERSIBLE DAMAGE IN SARCOIDOSIS: MORTALITY IMPACT OF END-STAGE ORGAN FAILURE IN A NATIONWIDE COHORT (SARCOGEAS REGISTRY)
Carlos Feijoo-Massó, A. Mayer-Fuentes, Alejandra Flores-Chávez, G. Policarpo-Torres et autres
0 citationsAnnals of the Rheumatic Diseases
POS1316 THREE SYSTEMIC LUPUS ERYTHEMATOSUS PHENOTYPES ACCORDING TO CLUSTER ANALYSIS OF CLINICAL AND IMMUNOLOGICAL CLASSIFICATION CRITERIA: A MULTICENTRE STUDY OF 773 PATIENTS
Andrés González García, M. Fabregate, Carlos Feijoo-Massó, Francesca Mitjavila et autres
0 citationsAnnals of the Rheumatic Diseases
POS1127 Predictors of Mortality in Sarcoidosis: A Nationwide Cohort Study from the SARCOGEAS Registry
A. Mayer-Fuentes, Carlos Feijoo-Massó, Alejandra Flores-Chávez, G. Policarpo-Torres et autres
1 citationAnnals of the Rheumatic Diseases
POS0852 NEUROLOGICAL INVOLVEMENT IN SJÖGREN'S DISEASE: PREVALENCE AND KEY CLINICAL ASSOCIATIONS FROM A SINGLE-CENTER COHORT
J. Álvarez Troncoso, B. Fachal Bugarín, Salustiano Iglesias, Óscar Porto Fuentes et autres
0 citationsAnnals of the Rheumatic Diseases
POS0311 SARCOIDOSIS AS A SYSTEMIC DISEASE: IDENTIFYING PATTERNS OF MULTIORGAN-SPECIFIC INVOLVEMENT AND EPIDEMIOLOGICAL PROFILING THROUGH GENERATIVE ARTIFICIAL INTELLIGENCE-DRIVEN CLUSTERING
Pilar Brito‐Zerón, Alejandra Flores-Chávez, Carlos Feijoo-Massó, G. Policarpo-Torres et autres
0 citationsAnnals of the Rheumatic Diseases
Inflammatory cerebral pseudotumour as a rare manifestation of neuro-Behçet's disease: A case report and literature review
Óscar Porto Fuentes, Laura Lacruz Ballester, Jorge Álvarez Troncoso, Clara Itzíar Soto Abánades et autres
2 citationsJournal of Neuroimmunology
Inflammatory Cerebral Pseudotumour as a Rare Manifestation of Neuro-Behçet's Disease: A Case Report and Literature Review
Óscar Porto Fuentes, Laura Lacruz Ballester, Jorge Álvarez Troncoso, Clara Itzíar Soto Abánades et autres
0 citationsSSRN Electronic Journal
1047 - IMPACTO CLÍNICO DE ANIFROLUMAB EN PRÁCTICA REAL: COHORTE MULTICÉNTRICA DE MEDICINA INTERNA EN ESPAÑA
Cristina Lavilla Olleros, Antonio Chamorro Fernández, Helena Martín Álvarez, Ana Madroñero et autres
0 citationsRevista Clínica Española
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.